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Abstract
Background: The purpose of this study was to observe whether invisible morphological changes are presented in
the two types of diabetes mellitus patients without diabetic retinopathy.
Methods: Twenty-six type 1 diabetes mellitus (T1DM) patients and 34 type 2 diabetes mellitus (T2DM) patients
without diabetic retinopathy (DR) were recruited for this study. They underwent complete examinations that
included stereoscopic color fundus photography and optical coherence tomography (OCT). The OCT patterns were
used to measure the macular retinal thickness (RT), the ganglion cell and inner plexiform layer (GC-IPL) complex
thickness, the inner nuclear layer (INL) thickness, the outer nuclear layer (ONL) thickness and the subfoveal choroidal
thickness (SFCT) using the enhanced depth imaging (EDI) patterns and the retinal fiber layer (RNFL) thickness
around the optic disc. All results were compared to those of age- and sex-matched control groups.
Results: In the patients with T1DM, the mean RT and GC-IPL complex thicknesses were significantly thinner than
those of the control group (p < 0.05). The RNFL was found to be thinner at the 9 o’clock position around the optic
disc in the patients compared with the control group. The SFCTs were similar in the controls and subjects. The INL
and ONL were decreased in parts of the pericentral and peripheral areas in the T1DM patients (p < 0.05) and
increased in the T2DM patients (p < 0.05).
Conclusions: This study demonstrated that in short-duration T1DM patients, the layers of the retina are affected
and that the neural tissue has begun to be lost. As diabetes develops, neurodegeneration may cause vascular
permeability, which causes thickening of the retinal layers.
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Background
The global incidence of diabetes mellitus (DM) is in-
creasing, and the number of patients is expected to
reach 3.66 billion by 2030 [1]. Diabetic retinopathy (DR)
is one of the most common and severe complications of
DM and is also the leading cause of blindness. In Amer-
ica, 40 % of type 2 diabetes mellitus (T2DM) patients
and 86 % of type 1 diabetes mellitus (T1DM) patients
suffer from DR [2, 3]. In China, the incidence of DR is
27.9 % in urban areas and 43 % in rural areas [4, 5]. Thus,
the early detection of DR is important for the preservation
of useful acuity in later life.
The present examinations of DR included direct
ophthalmoscopy, fundus photography, optical coherence
tomography (OCT) and fluorescence angiography. OCT is
a noninvasive technique that was developed to be rapid in
terms of its hardware and software attributes, and OCT
exhibits high levels of accuracy and definition in the de-
tection of early and small changes in retinal morphology.
The newly updated Carl Zeiss OCT software version 6.0
integrates FastTrac retinal tracking, FoveaFinder, ganglion
cell analysis, ONH and RNFL OU analyses, enhanced
depth imaging (EDI) and other powerful functions that
enable the acquisition of reliable data for clinical research.
In addition to the retinal layers, the choroid has also
attracted much interest due to its vascular structure and
supply of oxygen and nutrients to the outer retina. The
EDI pattern is also useful for clearly displaying choroid
thickness and structural abnormalities [6]. Increases and
decreases in macular and choroid thicknesses have been
observed in patients with and without diabetic retinopathy
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in previous studies, and different mechanisms have been
found to be responsible for these changes [7–11].
Our study aimed to fully utilize OCT to identify the




This was a cross-sectional, case–control study. The
design of this study followed of the principles of the
Declaration of Helsinki and was approved by the In-
stitutional Review Board of the RuiJin Hospital. Written
informed consent was obtained from all participants or
their parents (children who were under 16 years old). The
patients were recruited from the outpatient clinic of the
department of Endocrinology Medicine of the RuiJin Hos-
pital affiliated with the Shanghai Jiao Tong University
School of Medicine (Shanghai, China) between October
2013 and November 2014. The patients were diagnosed
with type 1 or type 2 diabetes mellitus by an endocrine
specialist and were treated with insulin or other medi-
cines. The normal control subjects were selected from the
medical examination center of the same hospital. They
were age- and sex-matched to the patients; were free of all
diagnoses of ocular disease, diabetes, or other systemic
disease; and underwent a complete ophthalmologic exam-
ination that included a visual acuity assessment, slit-lamp
examination with a handheld lens (Super Field; Volk
Optical, Inc., Mentor, OH), intraocular pressure (IOP) as-
sessment with a noncontact tonometer, and refraction,
color fundus photograph (TRC-50IX; Topcon Corp.), and
Cirrus high-definition optical coherence tomography
(HD-OCT, Carl Zeiss Meditec, Dublin, California). The
inclusion criteria were as follows: 1) a diagnosis of T1DM
or T2DM with no clinical retinopathy as observed
through dilated pupils by an experienced doctor using a
stereoscopic slit lamp with a handheld lens; 2) a best-
corrected visual acuity ≥20/25; and 3) refractive errors
below -6 or above +3 diopter equivalent spheres. The ex-
clusion criteria were significant media opacity, glaucoma,
uveitis, ocular trauma or surgery history, and other serious
systemic diseases. Additionally, age, sex, duration of
diabetes (in years) were recorded, and fasting glucose and
HbA1c levels were collected from the patients’ recent
blood reports (Tables 1 and 2).
OCT measurements
A Cirrus HD-OCT 4000 (software Version 6.0) was used
to obtain the macular images. The patients placed their
chins in a chinrest with their foreheads contacting a
headrest and fixated on a green target. The macular
cube 512 × 128 scan protocol was used to acquire all 128
OCT B-scans that covered an area of 6 × 6 mm and were
2 mm in length centered on the fovea. A mean retinal
thickness (RT) map of nine zones from the internal lim-
iting membrane to the retinal pigment epithelium was
automatically measured. We defined the foveal area (A1)
as a central circle with a diameter of 1 mm, the pericen-
tral area (A2-A5) as a donut-shaped ring centered on
the fovea with an inner diameter of 1 mm and an outer
diameter of 3 mm, and the peripheral area (A6-A9) as a
ring with an inner diameter of 3 mm and an outer diam-
eter of 6 mm (Fig. 1a).
The ganglion cell analysis algorithm was used to
measure the GC-IPL thickness within a 14.13 mm2
elliptical annulus centered on the fovea based on the
3-dimensional data generated from the macular cube
512 × 128 scan protocol. The outer boundary of the
retinal nerve fiber layer (RNFL) and the outer bound-
ary of the inner plexiform layer were automatically
segmented by the algorithm. The GC-IPL thicknesses
of the superotemporal, superior, superonasal, inferotem-
poral, inferior and inferonasal sectors were automatically
measured (Fig. 1b).
A one-line raster scan of the EDI pattern was per-
formed to obtain high-quality images of the retina and
macular choroid. The scan line was as close as possible
to the fovea in the horizontal (0°) and vertical (90°) di-
rections. Only images with signal strengths exceeding 6
were selected for the study. The thicknesses of the inner
nuclear layer (INL) and the outer nuclear layer (ONL)
were measured manually every 0.5 mm from the center
to the periphery in the nasal and temporal directions.
Each measurement was performed three times, and the
mean values were determined. The choroid thickness
was defined as the vertical distance from the hyper-
reflective line of Bruch’s membrane to the hyper-
reflective line of the inner surface of the sclera. The sub-
foveal choroidal thickness (SFCT) was measured in the
horizontally and vertically scanned images to obtain a
mean value (Fig. 2).
Table 1 Characteristics of the subjects
Parameters T1DM Control p value T2DM Control p value
Female/Male 17/9 14/11 0.572 18/16 23/13 0.467
BCVA 0.00(log MAR) 0.00(log MAR) 0.922 0.05(log MAR) 0.05(log MAR) 0.669
IOP, mmHg 17.53±4.27 16.27±3.03 0.357 14.54±2.22 16.07±3.41 0.834
Age, years 21.8±5.3 23.1±4.8 0.397 59.7±13.9 57.0±7.5 0.183
All values are presented as the mean ± SD, and differences were considered statistically meaningful when p < 0.05
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The optic disc cube scan protocol was used to obtain
the RNFL measurements from the T1DM patients. There
were 200 A-scans, and from each of 200 B-scans, the soft-
ware automatically determined the center of a disc with a
radius of 1.73 mm. The RNFL thicknesses of 12 sectors of
the optic disc that were defined like the hours on a clock
were measured and calculated using this software. The
data were recorded in the superior-to-temporal, inferior-
to-nasal, and clockwise directions (Fig. 1c).
Statistical analysis
Statistical analyses were performed using SPSS software
version 20.0 for IOS (IBM Corporation, Chicago, IL,
USA). All data are expressed as the mean ± standard
deviation (SD). A chi square test was used to assess the
difference in the female/male ratio between the patients
and controls. Analysis of variance (ANOVA) was used to
assess the differences in mean age, BCVA, IOP, fasting
glucose level, HbA1c and DM duration between the
patients and controls. The mean RT, GC-IPL complex,
INL, ONL and RNFL thicknesses in the diabetic patients
and controls were compared using independent t tests.
The results were considered statistically significant when
p < 0.05.
Results
In total, 26 T1DM patients and 34 T2DM patients were
analyzed in this study. Age- and sex-matched controls
were 25 and 36 respectively (Table 1). Both eyes of all
participants were scanned, and the left eyes were selected
for analysis. The mean RTs of all nine of the zones of the
T1DM subjects were thinner than those of the control
group, and the differences in zones A2 to A9 were sta-
tistically meaningful (p < 0.05); however, no significant
changes were found in the T2DM patients (Table 3). All
six sectors of the GCIPL complex in the T1DM patients
were thinner than those in the control group, but these
values were similar in the T2DM patients and controls
(Table 4). The INL and ONL of the T1DM patients were
both thinner at some of the tested points in the periphery
and pericentral areas (p < 0.05) and slightly thicker in the
fovea; the latter difference was not statistically meaningful
(Figs. 3 and 4). In contrast, the opposite pattern of results
was observed in the T2DM patients who displayed thicker
layers (Figs. 5 and 6).
The SFCTs were 294.44 ± 60.96 μm in the T1DM pa-
tients and 303.16 ± 60.23 μm in the T1DM control group
(p = 0.64). In the T2DM patients and their control group,
these values were 284 ± 84.89 μm and 254 ± 67.36 μm,
respectively (p = 0.32).
The RNFL thicknesses of the optic discs of the T1DM
patients were significantly decreased at the 9 o’clock
position (p = 0.005).
Discussion
Previous studies have reported changes in the macular
retinal thickness and the thicknesses of different layers
in patients with and without diabetic retinopathy [7–11].
The early diagnosis and early detection of functional
changes related to DR that occur prior to retinal morph-
ology changes are important for preventing DR. Some
researchers have found that retinal neurodegeneration
may occur in DR before any microcirculatory abnormal-
ities can be detected [12, 13]. Neural apoptosis and the
loss of ganglion cell bodies and glial reactivity are now
considered to be the main factors in DR [14, 15].
In this study, we observed significant decreases in the
RTs of the A2 to A9 zones and the thickness of all
Table 2 Differences between T1DM and T2DM patients
Parameters T1DM T2DM p value
Fasting blood glucose, mg/dL 6.22±1.30 6.37±1.37 0.248
HbAlc, % 7.84±2.39 6.56±0.65 0.072
DM duration, years 2.1±3.0 10.17±6.84 0.000*
All values are presented as the mean ± SD
*Statistically meaningful
Fig. 1 a. Macular retinal thickness map of nine zones of the left eyes based on OCT. b. Ganglion cell and inner plexiform layer complex thickness
maps of nine zones of the left eyes based on OCT. c. Retinal nerve fiber layer deviation map and clock positions around the optic discs of the left
eyes based on OCT
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sectors of the GC-IPL complex in the macular zones
of the T1DM patients. Additionally, among the tested
points, N2.0 in the INL and N0.5, N2.0, T0.5, T1.0,
and T2.0 in the ONL were found to be decreased in
the patients. In the RNFL, the 9 o’clock position, i.e.,
the nasal section, was found to be reduced in the patients.
In sharp contrast to the T1DM group, we did not observe
many positive findings in the T2DM patients. No mea-
sured RT or GC-IPL complex thicknesses were found to
be different between the T2DM patients and controls.
However, increased thicknesses in the testing points N1.5,
N2.0, T1.0, T1.5, and T2.0 in the INL and N0.5 and N1.0
in the ONL were observed. In the SFCT, we did not ob-
serve any changes in either the T1DM or T2DM patients.
To our knowledge, there were no previous ophthalmo-
logical studies of newly diagnosed T1DM patients. In
the present study, the mean disease durations were
2.1 ± 3.0 years for the type 1 DM patients and 10.17 ±
6.84 years for the type 2 DM patients (p < 0.05). The
T2DM patients exhibited no significant differences in the
measures of retinal thickness or the GC-ILP complex, but
these measures were decreased in the T1DM patients.
Similar results have been reported in other studies [8, 9],
which have detected either thickening or thinning of the
Fig. 2 Retinal layers shown in an OCT EDI pattern scan image
Table 3 The retinal thicknesses in nine zones in type 1 and type 2 DM patients and controls
Type 1 DM Control p value Type 2 DM Control p value
Superior 80.72±9.65 85.50±6.05 0.044* 82.74±8.91 85.24±6.47 0.316
Superotemporal 78.64±8.78 85.17±7.45 0.007* 81.13±8.19 82.59±6.29 0.527
Inferotemporal 80.00±7.09 85.29±5.29 0.005* 81.81±8.29 82.47±6.41 0.776
Inferior 78.28±7.01 82.35±6.34 0.041* 79.13±7.56 81.12±5.94 0.354
Inferonasal 79.96±6.49 84.63±6.61 0.016* 80.03±11.58 82.94±5.99 0.340
Superonasal 82.96±5.95 86.71±6.98 0.049* 84.19±10.49 86.59±6.54 0.399
All values are presented as the mean ± SD
*Statistically meaningful
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retina. The majority of these reports found that the retina
becomes thinner when DR is present [9, 16]. Together, all
of the above-mentioned findings lead to the conclusion
that the retinal and ganglion cell layer thicknesses are
correlated with DM duration. In the initial few years of
diabetes, the macular thickness decreases due to neural
tissue loss, but as diabetes progresses, these thicknesses
gradually increase due to vascular permeability in the ret-
ina [10, 11]. In patients without DR, Bronson-Castain
et al. [17] found that the RT was decreased in a group of
adolescent T2DM patients with a mean disease duration
of 2.1 years. However, the authors of this study expressed
doubt about the neural tissue theory based on the short
duration of DM in their adolescent patients.
Our results indicated that the neurodegenerative effects
on the retina probably occurred prior to vasculopathy in
the early stages of diabetes based on the variations in the
ages and disease durations of our population. Therefore,
our results do not mean that there were no changes in the
RTs of the T2DM patients; rather, the thickening of other
layers, such as the INL and ONL, which were observed in
the present study, probably masked these changes.
Due to technical limitations, we were unable to dir-
ectly measure the ganglion cell layer thickness, but the
newly updated OCT software provides accurate data
about the GC-IPL complex for clinical studies.
Other studies have also observed ganglion cell loss in
DR and nonproliferative diabetic retinopathy (NDR) pa-
tients [10], and axonal loss may lead to the thinning of
the RNFL [18]. Moreover, both ganglion cells loss and
axonal loss are correlated with HbAc1 and duration [19]
and worsen as disease severity increases. The pericentral
macular area has been found to be significantly thinner
in patients with minimal DR [18, 20] and thicker in pa-
tients with preproliferative diabetic retinopathy [19],
which suggests that neuronal abnormalities may precede
vascular abnormalities [11].
We found that the RNFL around the optic disc was
thinner in the patients than in the controls only at the 9
o’clock position, which may prove that RNFL degener-
ation occurs in the onset stage of diabetes [14, 21]; how-
ever, it is difficult to determine which area is the first to
be affected.
In the inner nuclear layer, the pericentral and periph-
eral macular thicknesses were decreased in the T1DM
patients compared to the controls, whereas they were
thicker in the T2DM group, and the same pattern of
Table 4 Thicknesses of the ganglion cell layer and inner plexiform layer in six sectors in the type 1 and type 2 DM patients and
controls
Type 1 DM Control p value Type 2 DM Control p value
Superior 80.72±9.65 85.50±6.05 0.044* 82.74±8.91 85.24±6.47 0.316
Superotemporal 78.64±8.78 85.17±7.45 0.007* 81.13±8.19 82.59±6.29 0.527
Inferotemporal 80.00±7.09 85.29±5.29 0.005* 81.81±8.29 82.47±6.41 0.776
Inferior 78.28±7.01 82.35±6.34 0.041* 79.13±7.56 81.12±5.94 0.354
Inferonasal 79.96±6.49 84.63±6.61 0.016* 80.03±11.58 82.94±5.99 0.340
Superonasal 82.96±5.95 86.71±6.98 0.049* 84.19±10.49 86.59±6.54 0.399
All values are presented as the mean ± SD
*Statistically meaningful
Fig. 3 Comparison of the inner nuclear layer thicknesses in the
perifoveal area between the type 1 diabetes patients and the control
group. *Statistically meaningful
Fig. 4 Comparison of the outer nuclear layer thicknesses in the
perifoveal area between the type 1 diabetes patients and controls.
*Statistically meaningful
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alterations was observed in the outer nuclear layer.
These results confirm our speculation that neurodegen-
eration occurs during the early stages of disease and that
the vascular permeability increases with disease duration
and leads to increased retinal thickness. However, the
differences were not significantly meaningful at all of the
tested points; thus, we may need to increase our sample
size. Only manual measurements and horizontal EDI
scans were used to determine the INL and ONL thick-
nesses, which limited our statistical power. Continuous
follow-up of these subjects is also needed for further
study.
The reports regarding choroidal thickness (CT) in dia-
betes patients seem to be consistent in that they have all
reported decreased CTs in subjects with proliferative
diabetic retinopathy or diabetic macular edema and a
lack of significant changes in NDR patients [22, 23] and
T1DM children without DR [24]. The breakdown of the
blood-retinal barrier, loss of retinal vasculature integrity
and the presence of hemodynamic abnormalities may
contribute to changes in the choroidal thicknesses of
diabetic eyes [25, 26]. In our study, the SFCTs of the
T1DM and T2DM patients were similar to those of the
controls, which may suggest that the choroid tissue is
affected later than the neuroretinal layer in diabetic
retinopathy.
Conclusion
We detected morphological changes in DM patients
with Cirrus HD-OCT, and the remarkable results ob-
served in the T1DM patients confirmed that the loss of
neural tissue begins in the early stages of diabetes. As
diabetes develops, neurodegeneration may be masked by
changes in vascular permeability that cause thickening
of the retinal layers.
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